Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (201-210 of 330) with videos related to

Pageof 33
Sort By:
Breast (Edinburgh, Scotland)|November 14, 2017
Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational studyArlindo R Ferreira, Ana Palha, Lurdes Correia, et al.
JAMA Oncology|March 17, 2017
Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based StudyAllison M Martin, Daniel N Cagney, Paul J Catalano, et al.
Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.
Breast (Edinburgh, Scotland)|July 30, 2016
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort studyArlindo R Ferreira, Ana Palha, Lurdes Correia, et al.
Human Vaccines & Immunotherapeutics|October 14, 2025
Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatmentChristine M Dang, Troy J Kemp, Nancy Roche, et al.
NPJ Breast Cancer|June 8, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancerAlbert Grinshpun, Douglas Russo, Wen Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast CancerAntonio Giordano, Priya U Kumthekar, Qingchun Jin, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Breast Cancer Research and Treatment|April 15, 2019
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastasesDaniel N Cagney, Nayan Lamba, Sofia Montoya, et al.
Pageof 33

Showing results (201-210 of 330) with videos related to

Sort By:
Pageof 33
Breast (Edinburgh, Scotland)|November 14, 2017
Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational studyArlindo R Ferreira, Ana Palha, Lurdes Correia, et al.
JAMA Oncology|March 17, 2017
Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based StudyAllison M Martin, Daniel N Cagney, Paul J Catalano, et al.
Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.
Breast (Edinburgh, Scotland)|July 30, 2016
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort studyArlindo R Ferreira, Ana Palha, Lurdes Correia, et al.
Human Vaccines & Immunotherapeutics|October 14, 2025
Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatmentChristine M Dang, Troy J Kemp, Nancy Roche, et al.
NPJ Breast Cancer|June 8, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancerAlbert Grinshpun, Douglas Russo, Wen Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast CancerAntonio Giordano, Priya U Kumthekar, Qingchun Jin, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progressionJun Nishida, Simona Cristea, Sudheshna Bodapati, et al.
Breast Cancer Research and Treatment|April 15, 2019
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastasesDaniel N Cagney, Nayan Lamba, Sofia Montoya, et al.
Pageof 33